483 Biogen Mar 2013

483 Biogen Mar 2013

Paul Bellamy FDA$119.00 - Available Now

FDA investigators audited the Biogen - Cambridge, MA, United States facility and issued inspectional observations (via FDA 483) on 15 Mar 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 15 Mar 2013
  • Location: Cambridge, United States
  • FEI: 1220951
Add To Cart